Helicobacter pylori therapy: effect on peptic ulcer disease.
about
Chronic gastritis.Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance.Helicobacter pylori and peptic ulcer disease.Helicobacter pylori: therapeutic targets.Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.Treating Helicobacter pylori--the best is yet to come?Update on the management of Helicobacter pylori infection, including drug-resistant organisms.Pathophysiology and clinical relevance of Helicobacter pylori.Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.Helicobacter pylori disease in childhood.Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.Current Strategies in Ulcer Management with Special Reference to the Use of Antibiotics.Determination of metronidazole in a rat stomach by HPLC for obtaining basic data of the eradication therapy of Helicobacter pylori.Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.Helicobacter pyloriEradication with Doxycycline—Metronidazole—Bismuth Subcitrate Triple TherapyNew Options in Eradication ofHelicobacter pylori
P2860
Q30374031-F1F97B06-C79D-471A-904B-DFA11772823DQ30451523-464A9319-B654-4D41-8E0F-1D3986FE7EB3Q33607500-68607EA8-EB12-4AFA-A11A-6967D65A5A02Q33667006-2259819F-CFAF-4089-910F-CA26AA8D3A79Q34289478-389E5E1E-6E05-4583-827F-43B1A1F793D8Q34410607-A623CF26-1E04-4F8A-8C00-B1AB23946D5BQ34619427-68922F40-CEA8-4386-B602-68A5EEB0B1AFQ35242580-CE169883-8C49-4F1A-89BB-00E8D26D6EEFQ36545248-456A2E15-8DE0-4150-94FD-B3E8D9072D85Q37083245-FA1FA17C-73CA-4A23-8591-FCA50D429FC6Q38723877-D92188D2-8E36-49D6-AF45-F10FCC2B2021Q41006302-86B459DF-77D1-46B6-858E-AF0F103E2C92Q42542863-DA4B6AB9-4B30-4690-AD65-7AF1EB3D4EDAQ45782093-75223AB0-A8A4-41D6-8BBF-DF8FB3080405Q49425208-F8142346-F0EF-4372-B798-CADE78D620D9Q54021480-942FBE40-7149-46F1-8B27-A4DAA19D0D88Q54394340-FB6FDEF5-F346-4E1B-BD8F-6599B0E60DB5Q57486982-4499FA03-9D80-4897-A9FA-2B8699595E1CQ58282204-953A58DB-23B6-4D46-BBEF-6ED9E66232F7
P2860
Helicobacter pylori therapy: effect on peptic ulcer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Helicobacter pylori therapy: effect on peptic ulcer disease.
@en
Helicobacter pylori therapy: effect on peptic ulcer disease.
@nl
type
label
Helicobacter pylori therapy: effect on peptic ulcer disease.
@en
Helicobacter pylori therapy: effect on peptic ulcer disease.
@nl
prefLabel
Helicobacter pylori therapy: effect on peptic ulcer disease.
@en
Helicobacter pylori therapy: effect on peptic ulcer disease.
@nl
P2860
P1476
Helicobacter pylori therapy: effect on peptic ulcer disease.
@en
P2093
P2860
P304
P356
10.1111/J.1440-1746.1991.TB01452.X
P577
1991-03-01T00:00:00Z